CAJ | 학술논문

目的：回顾分析不同手术处理方式对腮腺下极良性肿瘤术后味觉出汗综合征的预防作用。方法将临床收治的122例腮腺下极（包括后下极）良性肿瘤病例随机分为A，B，C，D 4组，A组作为对照组，采用传统腮腺腺叶及肿瘤切除术，B组应用单纯腮腺部分切除术，C组行保留腮腺筋膜的腮腺部分切除术，D组腮腺部分切除术后，术区覆盖异种脱细胞真皮基质。术后随访12～36个月，通过Minor试验了解味觉出汗综合征情况。结果 A组41例患者发生味觉出汗综合征24例（58．54％）。 B组35例，发生12例（34．29％）。 C组26例，发生3例（11．54％）。 D组20例，查见2例（10．00％）。 A组与B，C，D 3组任何一组比较，均存在差异（ P＜0．05）。 B组与C，D任意一组间比较，均存在差异（P＞0．05），C，D两组间差异不明显（P＞0．05）。结论对于腮腺下极良性肿瘤，腮腺部分切除术后保留腮腺筋膜或应用异种脱细胞真皮基质均可有效预防术后味觉出汗综合征的发生，但脱细胞真皮基质应用范围更为广泛。
목적：회고분석불동수술처리방식대시선하겁량성종류술후미각출한종합정적예방작용。방법장림상수치적122례시선하겁（포괄후하겁）량성종류병례수궤분위A，B，C，D 4조，A조작위대조조，채용전통시선선협급종류절제술，B조응용단순시선부분절제술，C조행보류시선근막적시선부분절제술，D조시선부분절제술후，술구복개이충탈세포진피기질。술후수방12～36개월，통과Minor시험료해미각출한종합정정황。결과 A조41례환자발생미각출한종합정24례（58．54％）。 B조35례，발생12례（34．29％）。 C조26례，발생3례（11．54％）。 D조20례，사견2례（10．00％）。 A조여B，C，D 3조임하일조비교，균존재차이（ P＜0．05）。 B조여C，D임의일조간비교，균존재차이（P＞0．05），C，D량조간차이불명현（P＞0．05）。결론대우시선하겁량성종류，시선부분절제술후보류시선근막혹응용이충탈세포진피기질균가유효예방술후미각출한종합정적발생，단탈세포진피기질응용범위경위엄범。
Objective To assess the effect of different treatments in prevention of Gustatory Sweating Syn-drome.Methods One hundred and twenty-two clinical patients with benign tumor in the posteroinferior of parotid land were divided into four groups according to surgical procedures .All patients(41 cases) in group A received conventional parotidectomy.Patients(35 cases) in group B received partial parotidectomy.Parotid fascias were retained in group C(26 cases).Heterogeneous acellular dermal matrix was used in group D (20 cases).The incidence of Frey's syndrome was as-sessed by minor's test.Results The gustatory sweating syndrome rate of the four groups was 58.54%,34.29%,11. 54%,10.00%respectively,group A was statistically different with any of other 3 groups(P<0.05).Differences existed between group B and C,group B and D(P<0.05).While there was no statistical differences between goup C and D (P>0.05).Conclusion The use of heterogeneous acellular dermal matrix or retention of parotid fascia after partial paroti -dectomy can both effectively reduce incidence rate of gustatory sweating syndrome for the patients with benign tumor in the posteroinferior of parotid land , but heterogeneous acellular dermal matrix has a wider range of clinical application when compared with parotid fascia .